Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 3
Submit an article Journal homepage
1,439
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Characterization of alpha-1-acid glycoprotein as a potential biomarker for breast cancer

Luo QiongDepartment of Breast and Thyroid Surgery, Affiliated Hengyang Hospital, Southern Medical University (Hengyang Central Hospital), Hengyang, Hunan, ChinaORCID Iconhttps://orcid.org/0000-0001-9147-7768View further author information
ORCID Icon &
Jun YinDepartment of Breast and Thyroid Surgery, Affiliated Hengyang Hospital, Southern Medical University (Hengyang Central Hospital), Hengyang, Hunan, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0558-0089View further author information
ORCID Icon
Pages 5818-5826 | Received 17 Nov 2021, Accepted 25 Jan 2022, Published online: 21 Feb 2022

References

  • Kosti O, Byrne C, Cocilovo C, et al. Phytohemagglutinin-induced mitotic index in blood lymphocytes: a potential biomarker for breast cancer risk. Breast Cancer. 2010;4:73–83.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Qiu L, Zhou Y, Yu Q, et al. Decreased levels of regulatory B cells in patients with acute pancreatitis: association with the severity of the disease. Oncotarget. 2018;9(90):360672–360682.
  • Steward LT, Gao F, Taylor MA, et al. Impact of radiation therapy on survival in patients with triple-negative breast cancer. Oncol Lett. 2014;7(2):548–552.
  • Coleman C. Early detection and screening for breast cancer [J]. Semin Oncol Nurs. 2017;33(2):141–155.
  • Shen S-L, Qiu F-H, Dayarathna TK, et al. Identification of Dermcidin as a novel binding protein of Nck1 and characterization of its role in promoting cell migration. Biochim Biophys Acta. 2011;1812(6):703–710.
  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283.
  • Kilpatrick ES, Lind MJ. Appropriate requesting of serum tumour markers. BMJ. 2009;339:b3111.
  • Amayo AA, Kuria JG. Clinical application of tumour markers: a review. East Afr Med J. 2009;86(12 Suppl):S76–83.
  • Marić P, Ozretić P, Levanat S, et al. Tumor markers in breast cancer--evaluation of their clinical usefulness. Coll Antropol. 2011;35(1):241–247.
  • Donepudi MS, Kondapalli K, Amos SJ, et al. Breast cancer statistics and markers. J Cancer Res Ther. 2014;10(3):506–511.
  • Manuali E, De Giuseppe A, Feliziani F, et al. CA 15–3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade. BMC Veterinary Research. 2012;8(1):86.
  • Shao Y, Sun X, He Y, et al. Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer. PLoS One. 2015;10(7):e0133830.
  • Kabel AM. Tumor markers of breast cancer: new prospectives. Jos. 2017;3(1):5–11.
  • Ceciliani F, Pocacqua V. The acute phase protein α1-acid glycoprotein: a model for altered glycosylation during diseases. Curr Protein Pept Sci. 2007;8(1):91–108.
  • Duché J, Urien S, Simon N, et al. Expression of the genetic variants of human alpha-1-acid glycoprotein in cancer. Clin Biochem. 2000;33(3):197–202.
  • Hervé F, Duché J, Jaurand M. Changes in expression and microheterogeneity of the genetic variants of human α1-acid glycoprotein in malignant mesothelioma. J Chromatogr B Biomed Sci Appl. 1998;715(1):111–123.
  • Crestani B, Rolland C, Lardeux B, et al. Inducible expression of the alpha1-acid glycoprotein by rat and human type II alveolar epithelial cells. J Immunol. 1998;160(9):4596–4605.
  • Thompson DK, Haddow JE, Smith DE, et al. Elevated serum acute phase protein levels as predictors of disseminated breast cancer. Cancer. 1983;51(11):2100–2104.
  • Kailajärvi M, Ahokoski O, Virtanen A, et al. Early effects of adjuvant tamoxifen therapy on serum hormones, proteins and lipids. Anticancer Res. 2000;20(2B):1323–1327.
  • Kim JG, Kim EO, Jeong BR, et al. Visfatin stimulates proliferation of MCF-7 human breast cancer cells. Mol Cells. 2010;30(4):341–345.
  • Fang T, Cui M, Sun J, et al. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas. Oncotarget. 2015;6(18):16106–16119.
  • Jabir RS, Ho GF, Annuar MABA, et al. Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients. Biomarkers. 2018;23(2):142–146.
  • Elg SA, Mayer AR, Carson LF, et al. Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovarian carcinoma. Cancer. 1997;80(8):1448–1456.
  • Chen I-H, Aguilar HA, Paez Paez JS, et al. Analytical pipeline for discovery and verification of glycoproteins from plasma-derived extracellular vesicles as breast cancer biomarkers. Anal Chem. 2018;90(10):6307–6313.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.